Sarepta Therapeutics (SRPT) Earnings Date, Estimates & Call Transcripts $39.99 +2.05 (+5.40%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Sarepta Therapeutics Earnings Summary Sarepta Therapeutics issued Q1 2025 earnings on May 6, 2025, reporting an EPS of -$3.42, which missed the consensus estimate of $2.20 by $5.62. Quarterly revenue rose 80.2% year-over-year to $744.86 million, above analysts' expectations of $685.75 million. With a trailing EPS of -$2.69 and a P/E Ratio of 31.99, Sarepta Therapeutics' earnings are expected to grow 309.74% next year, from $2.67 to $10.94 per share. Upcoming Q2 Earnings DateAug. 6After Market ClosesEstimatedConsensus EPS (May. 6) $2.20 Actual EPS (May. 6) -$3.42 Missed By -$5.62 Actual Revenue (May. 6) $744.86MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K) Slide DeckSRPT Upcoming EarningsSarepta Therapeutics' next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Sarepta Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sarepta Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSRPT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SRPT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Sarepta Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$2.70$2.45$0.55Q2 20253$1.99$2.69$2.44Q3 20253$2.61$2.81$2.73Q4 20253$2.85$3.60$3.11 FY 2025 12 $4.75 $11.55 $8.83 Q1 20261$2.44$2.44$2.44Q2 20261$2.76$2.76$2.76Q3 20261$2.82$2.82$2.82Q4 20261$2.62$2.62$2.62 FY 2026 4 $10.64 $10.64 $10.64 Q1 20271$2.90$2.90$2.90 Sarepta Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------5/6/2025Q1 2025$2.20-$3.42 -$5.62-$4.60$685.75M$744.86M8/7/2024Q2 2024$0.01$0.07+$0.06$0.07$394.38M$362.90M5/1/2024Q1 2024-$0.11$0.73+$0.84$0.39$375.52M$413.50M2/28/2024Q4 2023-$0.03$0.47+$0.50$0.47$387.18M$396.80M11/1/2023Q3 2023-$1.63$0.37+$2.00-$0.46$285.33M$331.80M8/2/2023Q2 2023-$1.89-$0.27+$1.62-$0.27$255.99M$261.20M Sarepta Therapeutics Earnings - Frequently Asked Questions When is Sarepta Therapeutics's earnings date? Sarepta Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on SRPT's earnings history. Did Sarepta Therapeutics beat their earnings estimates last quarter? In the previous quarter, Sarepta Therapeutics (NASDAQ:SRPT) missed the analysts' consensus estimate of $2.20 by $5.62 with a reported earnings per share (EPS) of ($3.42). Learn more on analysts' earnings estimate vs. SRPT's actual earnings. How can I listen to Sarepta Therapeutics's earnings conference call? The conference call for Sarepta Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Sarepta Therapeutics's conference call transcript? The conference call transcript for Sarepta Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Sarepta Therapeutics generate each year? Sarepta Therapeutics (NASDAQ:SRPT) has a recorded annual revenue of $2.23 billion. How much profit does Sarepta Therapeutics generate each year? Sarepta Therapeutics (NASDAQ:SRPT) has a recorded net income of -$535.98 million. SRPT has generated -$2.69 earnings per share over the last four quarters. What is Sarepta Therapeutics's price-to-earnings ratio? Sarepta Therapeutics (NASDAQ:SRPT) has a trailing price-to-earnings ratio of 31.99 and a forward price-to-earnings ratio of 14.98. What is Sarepta Therapeutics's EPS forecast for next year? Sarepta Therapeutics's earnings are expected to grow from $2.67 per share to $10.94 per share in the next year, which is a 309.74% increase. More Earnings Resources from MarketBeat Related Companies ITCI Earnings Date GMAB Earnings Date RDY Earnings Date VTRS Earnings Date MRNA Earnings Date ASND Earnings Date QGEN Earnings Date ROIV Earnings Date RVMD Earnings Date ELAN Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:SRPT) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sarepta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sarepta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SRPT Stock Free SRPT Stock Alerts